Rhizoma coptidis traditional Chinese medicine composition as well as preparation process, quality control method and application thereof
Through the combined use and extraction technology of Coptis chinensis, Astragalus, American cockroach, sheep genus and dendrobium, the problem of difficult to treat acute and chronic oral ulcers and gum problems in the prior art is solved, and efficient treatment of these problems is achieved and Quality control provides a traditional Chinese medicine prescription suitable for all oral ulcers.
Patent Information
- Application Number
- CN202411285935.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-13
- Publication Date
- 2024-12-06
AI Technical Summary
The existing traditional Chinese medicine prescriptions can only treat chronic oral ulcers, and it is difficult to effectively treat acute oral ulcers at the same time, and the treatment effect on gum problems is limited.
Coptis chinensis and astragalus as monarchs, and cockroaches, chrysanthemums, and dendrobium as prescriptions for prescriptions and adjuvants. The combination of alcohol and water extracts can increase the content of active ingredients in the composition and pass through high-efficiency liquid. Chromatographic detection performs quality control to prepare traditional Chinese medicine compositions suitable for acute and chronic oral ulcers and gum problems.
It has achieved efficient treatment of acute and chronic oral ulcers and gum problems, and provided a traditional Chinese medicine prescription suitable for all oral ulcers. It has cleared heat and did not damage the yin, nourished yin and did not hinder the spleen, combined with cold and heat, nourished qi and supported toxins, and dried dampness. The effects of detoxification and astringent sores and sagging improve the therapeutic effect and product quality.
Smart Images

Figure CN119074859A_ABST
Abstract
Description
Technical Field
[0001] The invention discloses a Chinese herbal composition of Rhizoma Coptidis and a preparation process, a quality control method and an application thereof, and specifically relates to a Chinese herbal composition of Rhizoma Coptidis suitable for treating acute and chronic oral ulcers, a process for preparing the composition, a method for controlling the quality of the composition, and an application of the composition in oral products, and belongs to the technical field of traditional Chinese medicine. Background Art
[0002] Oral ulcers are a common disease in the oral cavity, and the sites of occurrence are mostly the tongue, lips, etc. The cause of oral ulcers is still unclear, and a variety of factors can induce it. For example, acute oral ulcers are usually caused by bacterial infection, also known as bacterial stomatitis. When bacteria invade the body, they may induce the disease, such as Staphylococcus aureus, Escherichia coli, Streptococcus, etc. Patients will experience symptoms such as local pain and difficulty in eating. In severe cases, fever may occur. During treatment, oral cefixime, amoxicillin, azithromycin and other drugs need to be taken under the guidance of a doctor. Another example is chronic oral ulcers, also known as "mouth sores", which are superficial ulcers that occur on the oral mucosa. They can range in size from rice grains to soybeans, and are round or oval in shape. The ulcer surface is concave and surrounded by congestion. It has the characteristics of periodicity, recurrence and self-limitation, but its etiology and pathogenic mechanism are still unclear. The triggering factors may be local trauma, mental stress, food, drugs, changes in hormone levels and vitamin or trace element deficiencies. The treatment is mainly local treatment, and systemic treatment is required for severe cases. At present, drug therapy can achieve good treatment effects for the triggering factors of oral ulcers. Since chronic oral ulcers are also self-limiting, they can generally heal on their own in about 1 week. However, when oral ulcers are long-term or recurrent, they still bring many inconveniences to patients' daily life and work.
[0003] Traditional Chinese medicine treatment for oral ulcers is often based on dialectical treatment according to traditional Chinese medicine theory, such as spleen and stomach fire type: it is advisable to clear away heat and purge fire, cool blood and relieve constipation, and the Chinese medicine prescriptions include Lianggesan, Qingweisan, Yunujian, etc.; heart fire type: it is advisable to clear the heart and reduce fire, cool blood and promote diuresis, and the Chinese medicine prescriptions include Daochisan, Xiexintang, Xiaojiziyin, etc.; Yin deficiency and fire type: it is advisable to nourish yin and clear heat, and the Chinese medicine prescriptions include Liuwei Dihuangtang, Qiju Dihuangtang, Ganluyin, etc. At present, there is no Chinese medicine prescription that is suitable for both acute and chronic oral ulcers.
[0004] In the prior art, Chinese patent CN1277573C discloses a medicine for treating oral ulcers, which is prepared from asparagus, ophiopogon, raw rehmannia, cooked rehmannia, dendrobium, artemisia selengensis, fructus aurantii, licorice, scutellaria, coptis root, cimicifuga, moutan bark, honey, raw astragalus, cornus officinalis, raw loquat leaves, and fructus ligustri lucidi in proportion, and has the effects of clearing away heat and nourishing yin, astringing sores and promoting tissue regeneration, and improving the body's immunity, and has a significant therapeutic effect on recurrent oral ulcers.
[0005] Chinese patent CN100406030C discloses a Chinese medicine preparation for treating oral ulcers, which is made of chrysanthemum, liquorice, pearl, borneol and appropriate auxiliary materials to prepare oral preparations, which are suitable for purging fire, cooling blood and detoxifying. Among them, for the positive evidence of heat evil, chrysanthemum, which has the functions of dispersing wind, clearing heat, detoxifying and reducing swelling, is used as the main ingredient; pearl, which is cold in nature and sweet in taste, is used to clear heat, detoxify, astringe sores and promote tissue regeneration; borneol is pungent, dispersing, bitter and purging, clearing heat, cooling blood and relieving pain as the auxiliary ingredient; glycyrrhizic acid is sweet and yin-transforming, and relieves urgency and relieves pain as the envoy. All medicines are used together, which has the merits of detoxifying and relieving pain, removing dead flesh and promoting tissue regeneration, and can also reduce swelling and relieve pain. It has been proved by experiments that the preparation has obvious effects of removing dead flesh and promoting tissue regeneration, anti-inflammatory, analgesic and antibacterial effects.
[0006] Chinese patent CN101837045A discloses an American cockroach drug composition for treating oral ulcers and its preparation method, which uses a mixture of American cockroach extract and winter rubescens as active ingredients, fully exerts the effect of American cockroach extract, and effectively improves the efficacy of oral ulcer disease. According to the clinical experimental data of the cure rate of oral ulcer patients, the three-day cure rate of the treatment group using the American cockroach drug composition is more than double that of the control group using Huasu tablets. Summary of the invention
[0007] One of the purposes of the present invention is to provide a Chinese medicinal composition of Coptis chinensis, which has the effects of invigorating qi and removing toxins, drying dampness and detoxifying, and healing sores and wounds, and has a good therapeutic effect on acute and chronic oral ulcers and gum problems caused by the same reasons.
[0008] Another object of the present invention is to provide a preparation process of the Chinese herbal composition of Coptis chinensis, by which the content of effective substances such as epiberberine, coptis chinensis, palmatine, berberine, calycosin glucoside, and calycosin can be effectively increased by subjecting the monarch drugs Coptis chinensis and Astragalus membranaceus in the formula to alcohol extraction; and the finished drug, the assistant drug American cockroach, and the adjuvant drugs Acanthopanax chinensis and Dendrobium candidum are subjected to water extraction, thereby improving the efficacy of the composition.
[0009] Another object of the present invention is to provide a quality control method for the Coptis chinensis Chinese medicine composition, selecting calycosin glucoside, calycosin isoflavones, berberine hydrochloride, and bamipine hydrochloride as the main indicator components of the Coptis chinensis formula fingerprint, and controlling the content of effective extracts of the monarch medicines Astragalus and Coptis chinensis in the formula to achieve quality control of the effective ingredients in the Coptis chinensis Chinese medicine composition.
[0010] Another object of the present invention is to provide an application of the Rhizoma Coptidis Chinese medicinal composition, using the Rhizoma Coptidis Chinese medicinal composition as an effective ingredient of Rhizoma Coptidis toothpaste, providing a new approach for using the Rhizoma Coptidis Chinese medicinal composition through toothpaste to treat acute and chronic oral ulcers.
[0011] The present invention is achieved through the following technical solutions:
[0012] (I) The present invention provides a Chinese herbal medicine composition of Rhizoma Coptidis, which uses Rhizoma Coptidis or its extract, Astragalus or its extract, American cockroach or its extract, Aconite or its extract, Dendrobium or its extract as effective ingredients, and controls the content of calycosin glucoside ≥0.080%, the content of calycosin ≥0.030%, the content of berberine hydrochloride ≥0.080%, and the content of palmatine hydrochloride ≥0.110% in the Chinese herbal medicine composition of Rhizoma Coptidis.
[0013] In terms of weight, the composition comprises 10 to 20 parts of coptis chinensis or its extract, 24 to 48 parts of astragalus or its extract, 10 to 20 parts of american cockroach or its extract, 20 to 40 parts of chrysanthemum officinale or its extract, and 10 to 20 parts of dendrobium or its extract.
[0014] (II) The present invention provides a preparation process for the above-mentioned Chinese medicine composition of Coptis chinensis, which at least comprises the following operations:
[0015] (1) taking rhizomes of Coptis chinensis, drying and crushing them, adding ethanol, and then extracting them in a water bath, concentrating the extract under reduced pressure to a paste, and finally freeze-drying and grinding them into powder to obtain a Coptis chinensis extract;
[0016] (2) taking the rhizome of Astragalus, drying and crushing it, adding ethanol, and then extracting it in a water bath, concentrating the extract under reduced pressure to a paste, and finally freeze-drying it and grinding it into powder to obtain an Astragalus extract;
[0017] (3) taking an American cockroach, drying and crushing it, and then refluxing it with pure water, concentrating the extract under reduced pressure to a paste, and finally freeze-drying it and grinding it into powder to obtain an American cockroach extract;
[0018] (4) taking chrysanthemum and dendrobium according to the ratio, drying and crushing them, and then refluxing them with pure water, concentrating the extract under reduced pressure to a paste, and finally freeze-drying and grinding them into powder to obtain chrysanthemum extract and dendrobium extract;
[0019] (5) The extracts are mixed according to the ratio to obtain a Chinese herbal medicine composition of Coptis chinensis.
[0020] Furthermore, in the operation (1), the rhizome of Coptis chinensis is dried and crushed into 60 mesh, 60-80% ethanol is added, and the mixture is extracted in a water bath at 50-60° C. for 2-3 hours at a solid-liquid ratio of 1:10-15, and the extraction is repeated twice. The extracts are combined and then concentrated under reduced pressure.
[0021] In the operation (2), the rhizome of Astragalus membranaceus is dried and crushed into 60 mesh, 70-80% ethanol is added, and the mixture is extracted in a water bath at 50-60° C. for 1-2 h at a solid-liquid ratio of 1:15-20, and the extraction is repeated twice. The extracts are combined and then concentrated under reduced pressure.
[0022] In the operations (3) and (4), the American cockroach is dried and crushed to 60 mesh, and the ophiopogon and dendrobium are dried and crushed to 60 mesh; the reflux extraction comprises performing a first reflux extraction for 20 to 40 minutes with pure water at a solid-liquid ratio of 1:6 to 10, filtering to obtain a first filtrate, adding pure water at a solid-liquid ratio of 1:6 to 8 for a second reflux extraction for 20 to 40 minutes, filtering to obtain a second filtrate, and combining the two filtrates for reduced pressure concentration.
[0023] (III) The present invention provides a quality control method for the above-mentioned Chinese medicine composition of Coptis chinensis, comprising the following steps:
[0024] S1. Prepare a test solution and a reference solution of a Chinese medicinal composition of Coptis chinensis;
[0025] S2. Take the test solution and the reference solution and perform HPLC detection to obtain the corresponding characteristic spectrum, and then use the characteristic spectrum of the reference solution as a reference spectrum to construct a characteristic spectrum of the Chinese medicine composition of Coptis chinensis;
[0026] S3. The characteristic peaks of the characteristic spectrum of the Coptis chinensis Chinese medicine composition are used as the quality control standard of the Coptis chinensis Chinese medicine composition.
[0027] In the step S1, 0.5 g of the Chinese medicinal composition of Coptis chinensis is taken, 25 ml of 50% methanol-hydrochloric acid is added, and the power is controlled to 300 W and the frequency is controlled to 50 kHz for ultrasonic treatment for 30 minutes to obtain a test solution.
[0028] In the step S1, take calysin glucoside, palmatine hydrochloride, berberine hydrochloride, and calysin glucoside, add methanol to prepare a mixed solution containing 10 μg of calysin glucoside, 40 μg of palmatine hydrochloride, 180 μg of berberine hydrochloride, and 40 μg of calysin glucoside per 1 ml, and obtain a reference solution.
[0029] In step S2, during the HPLC detection, a C18 chromatographic column is used; acetonitrile is used as mobile phase A, and 0.2% phosphoric acid solution is used as mobile phase B, and gradient elution is performed; the flow rate is 1.0 ml / min; the detection wavelength is 260 nm; and the column temperature is 25° C.
[0030] The gradient elution process is as follows:
[0031] 0-15min, mobile phase A: 10%→20%, mobile phase B: 90%→80%;
[0032] 15-30 min, mobile phase A: 20% → 30%, mobile phase B: 80% → 70%;
[0033] 30-50 min, mobile phase A: 30%→50%, mobile phase B: 70%→50%.
[0034] (IV) The present invention provides an application of the above-mentioned Chinese herbal composition of Coptis chinensis in the preparation of Coptis chinensis toothpaste, wherein the Coptis chinensis toothpaste uses the Chinese herbal composition of Coptis chinensis, abrasives, moisturizers, thickeners, foaming agents, fragrances, water, etc. as main raw materials, and the content of the Coptis chinensis extract in the Coptis chinensis toothpaste is controlled to be ≥1.5 mg / 100 g, and the Coptis chinensis extract includes epiberberine, coptisine, palmatine and berberine.
[0035] Compared with the prior art, the present invention has the following advantages and beneficial effects:
[0036] (1) The Chinese medicine composition of Rhizoma Coptidis provided by the present invention is suitable for the treatment of acute oral ulcers. Based on TCM syndrome differentiation, acute oral ulcers are caused by the blazing heart fire and the pathogenic heat inflaming the meridians. Therefore, the present invention uses Rhizoma Coptidis and Radix Astragali as the main medicines, which have the effects of purging fire and detoxifying, invigorating qi and supporting toxins, and draining pus. Rhizoma Coptidis clears the heat of the heart and spleen in the middle and upper parts of the body, and Radix Astragali invigorates the spleen and lungs to support the toxins accumulated in the skin and flesh of the mouth. At the same time, Radix Astragali is diuretic and can promote the heat of the heart and spleen to be eliminated through urination. At present, there is no use of Rhizoma Coptidis and Radix Astragali as the main medicines of the Chinese medicine composition for acute oral ulcers.
[0037] (2) The Chinese herbal medicine composition of Rhizoma Coptidis provided by the present invention is also suitable for the treatment of chronic oral ulcers. Chronic oral ulcers refer to oral ulcerous lesions that are difficult to heal clinically and can be caused by a variety of diseases. The "Standards for Diagnosis and Therapeutic Effect of Chinese Medicine Diseases and Syndromes" divides chronic oral ulcers into two types: Yin deficiency and fire excess and spleen and kidney yang deficiency. The ministerial drugs, the guiding drugs and the adjuvant drugs in the present invention not only solve the disadvantages of using bitter and cold drugs to clear away heat and toxicity and damage the spleen and stomach, but also lead the drugs to the heart, spleen and kidney, so that the whole prescription can not only relieve the heat of the heart and spleen, but also nourish the yin of the kidney. At the same time, the adjuvant drug Dendrobium can prevent the long-term heat evil from damaging the yin of the lungs and kidneys, causing chronic oral ulcers belonging to lung and kidney yin deficiency. At present, there is no compatibility of American cockroaches, chrysanthemum and Dendrobium in Chinese herbal medicine compositions related to oral ulcers.
[0038] (3) The Chinese herbal composition of Coptis chinensis provided by the present invention can also alleviate gum problems, including clearing away internal heat, removing internal heat, protecting gums, and improving gum health. Therefore, it can also be used as one of the effective ingredients in preparing toothpaste, so that the toothpaste has the new efficacy of treating acute and chronic oral ulcers and alleviating gum problems.
[0039] (4) The present invention aims at the different characteristics and extraction conditions of each active ingredient in the Rhizoma Coptidis Chinese medicine composition, comprehensively considers the characteristics of various active ingredients, and proposes a preparation process specifically for the Rhizoma Coptidis Chinese medicine composition, which can fully guarantee the content of each active ingredient in the composition. At the same time, the content of the active ingredient is detected by a dedicated quality control method, which can ensure the quality requirements of industrially produced products and make it have good clinical treatment effects.
[0040] In summary, the present invention provides a Chinese medicine formula suitable for all oral ulcers. The Chinese medicine formula adopts Rhizoma Coptidis and Radix Astragali as main medicines, Periplaneta Americana as auxiliary medicine, and Herba Capillaris and Herba Dendrobii as adjuvants. The formula is comprehensively considered based on the specific effective ingredients in various medicinal materials, thereby solving the reasonable matching and control of the specific effective ingredients in the Chinese medicine formula, achieving the high-efficiency and high-quality effect of the Chinese medicine formula in acute oral ulcers, chronic oral ulcers (including recurrent oral ulcers) and gum problems caused by the same causes of oral ulcers, and having good clinical application value. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] Figure 1 is the chromatogram of the blank solution.
[0042] Figure 2 The chromatogram is of the mixed reference substance.
[0043] Figure 3 This is the chromatogram of the water extract of the Coptis chinensis formula.
[0044] Figure 4 This is the chromatogram of the alcohol extract of Coptis chinensis components.
[0045] Figure 5 This is an overlay of the HPLC fingerprints of the water extract and alcohol extract of the Coptis chinensis formula.
[0046] Figure 6 This is the chromatogram of the aqueous extract of the Rhizoma Coptidis formula in 50% methanol (100:1).
[0047] Figure 7 This is the chromatogram of the water extract of the Rhizoma Coptidis formula in 50% methanol-hydrochloric acid (100:1).
[0048] Figure 8 This is the chromatogram of the ethanol extract of the Rhizoma Coptidis formula in 50% methanol (100:1).
[0049] Fig. 9 This is the chromatogram of the ethanol extract of the Rhizoma Coptidis formula in 50% methanol-hydrochloric acid (100:1).
[0050] Fig.10 This is the chromatogram of the methanol-hydrochloric acid (100:1) aqueous extract of the Coptis chinensis formula.
[0051] Fig.11 This is the chromatogram of the water extract of the Rhizoma Coptidis formula in 50% methanol-hydrochloric acid (100:1).
[0052] Fig.12 This is the chromatogram of the water extract of the Rhizoma Coptidis formula in 30% methanol-hydrochloric acid (100:1).
[0053] Fig.13 This is the chromatogram of the methanol-hydrochloric acid (100:1) alcohol extract of the Coptis chinensis formula.
[0054] Fig.14 This is the chromatogram of the ethanol extract of the Rhizoma Coptidis formula in 50% methanol-hydrochloric acid (100:1).
[0055] Fig.15 This is the chromatogram of the ethanol extract of the Rhizoma Coptidis formula in 30% methanol-hydrochloric acid (100:1).
[0056] Fig.16 Oral mucosal tissues of rats in each group after treatment (HE, 40×).
[0057] Fig.17 The changes of oral ulcer area in rats of each group.
[0058] Fig.18 This is the effect of the Coptis chinensis formula on the levels of inflammatory factors in rat serum.
[0059] Fig.19 This is the effect of the Coptis chinensis formula on the gene expression of NLRP3 transcription factor in RAU rats.
[0060] Fig. 20 To investigate the effect of Coptis chinensis formula on the expression of NF-κBp65, p-IκBa, and IKKα proteins in oral mucosal tissue of RAU rats. DETAILED DESCRIPTION
[0061] The invention objectives, technical solutions and beneficial effects of the present invention are further described in detail below.
[0062] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the claimed invention, and unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention belongs.
[0063] The present invention is intended to treat the narrower applicability of existing Chinese medicine prescriptions for treating chronic oral ulcers such as recurrent oral ulcers, a kind of novel Chinese medicine prescription that can treat chronic oral ulcers and acute oral ulcers, each medicinal material is reasonably compatible in the Chinese medicine prescription, the symptoms of all oral ulcers can be fully solved, there is heat-clearing without damaging yin, nourishing yin without hindering spleen, cold medicine does not damage spleen and stomach, cold and heat combination, Qi-invigorating and poison-supporting, dampness-drying and detoxifying, sore-retaining and mouth-closing effect, and simultaneously, there is also a good therapeutic effect for the gum problem caused by the same cause of acute and chronic oral ulcers. Although the existing Chinese medicine prescription (such as patent CN100406030C) can treat recurrent oral ulcers, it is only for the positive evidence of pathogenic heat, and the effect of dispersing wind, clearing heat, detoxifying and detumescence is achieved with Fructus Aurantii as the monarch medicine, and its treatment is not comprehensive, and it is difficult to solve the symptoms caused by other causes.
[0064] From the perspective of traditional Chinese medicine, oral ulcers belong to the categories of oral sores, oral ulcers, oral thrush, and oral ulcers. They are often related to excessive heat in the heart and spleen, or involve the lungs and kidneys, lung and kidney yin deficiency, and virtual fire inflammation in the mouth, which also causes this disease. As far as the present invention is concerned, since it is intended to provide a Chinese herbal composition of Coptis chinensis suitable for treating acute and chronic oral ulcers, therefore, for the Chinese herbal composition of Coptis chinensis, its prescription is composed of Coptis chinensis or its extract, Astragalus membranaceus or its extract, American cockroach or its extract, Herba scutellariae or its extract, and Herba Dendrobii or its extract, wherein Coptis chinensis and Herba Astragali are monarch drugs, Herba scutellariae is ministerial drug and messenger drug, and Herba scutellariae and Herba Dendrobii are adjuvant drugs.
[0065] Specifically:
[0066] Main drug: Coptis chinensis, bitter, cold. It enters the large intestine, heart, and liver meridians, clears away heat and dampness, and purges fire and detoxifies; Astragalus membranaceus, sweet, slightly warm, enters the lung and spleen meridians, invigorates qi, supports sores, promotes tissue regeneration, and promotes diuresis. The two drugs are used together to have the effects of purging fire and detoxifying, invigorating qi, and supporting toxins, and draining pus. Coptis chinensis clears the heat of the heart and spleen in the middle and upper parts of the body, and Astragalus membranaceus invigorates the qi of the spleen and lungs to support the toxins accumulated in the mouth, skin, and flesh. At the same time, Astragalus membranaceus promotes diuresis and can promote the heat of the heart and spleen to be eliminated through urination.
[0067] Minister drug, Envoy drug: American cockroach: salty, cold, enters the heart, liver, spleen, and kidney meridians, reduces swelling and detoxifies, disperses blood stasis and heals sores, strengthens the monarch drug to detoxify and heals sores, promotes tissue regeneration and heals wounds, and is a non-bitter and cold drug that has the effect of detoxifying and regenerating tissue, avoiding the drawbacks of most doctors using bitter and cold drugs to clear away heat and toxins and damage the spleen and stomach. This drug is also an assistant drug, leading the drug to the heart, spleen, and kidneys, so that the whole prescription can both relieve the heat of the heart and spleen and nourish the yin of the kidney.
[0068] Adjuvant: Herba Dendrobii: pungent, slightly bitter, warm, enters the lung, liver, and stomach meridians, removes dampness, detoxifies and reduces swelling, and is an anti-adjuvant. Its warm nature restrains the coldness of other medicines, and at the same time enhances the efficacy of detoxification and swelling. Herba Dendrobii: sweet, slightly cold, enters the stomach and kidney meridians, benefits the stomach and produces fluid, nourishes yin and moistens dryness, nourishes the yin of the lungs, stomach, and kidneys, promotes the circulation of water, nourishes the mouth, and prevents the long-term heat evil from damaging the yin of the lungs and kidneys, causing chronic oral ulcers that belong to the deficiency of yin of the lungs and kidneys.
[0069] The whole formula can be used together to clear away heat without damaging yin, nourish yin without hindering the spleen, and is a cold medicine without damaging the spleen and stomach. The combination of cold and hot is suitable for both acute and chronic oral ulcers. The whole formula can be used together to have the effects of invigorating qi and expelling toxins, drying dampness and detoxifying, and astringing sores and closing the mouth.
[0070] Furthermore, in order to ensure the therapeutic effect of the Coptis chinensis Chinese medicine composition described in the present invention, it is very important to reasonably control the content of specific effective ingredients in the Coptis chinensis Chinese medicine composition. Therefore, the present invention also provides a preparation process and quality control method based on the Coptis chinensis Chinese medicine composition.
[0071] The specific process of its preparation technology can be summarized as follows:
[0072] Take the rhizome of Coptis chinensis, dry and crush it into 60 mesh, add 60-80% ethanol, extract in a water bath at 50-60°C for 2-3 hours with a solid-liquid ratio of 1:10-15, extract twice, combine the extracts and concentrate them under reduced pressure to a paste, finally freeze-dry and grind them into powder to obtain the Coptis chinensis extract.
[0073] Take the rhizome of Astragalus, dry and crush it into 60 mesh, add 70-80% ethanol, extract in a water bath at 50-60°C for 1-2h with a solid-liquid ratio of 1:15-20, extract twice, combine the extracts and concentrate them under reduced pressure to a paste, finally freeze-dry and grind them into powder to obtain the Astragalus extract.
[0074] The American cockroach is taken, dried and crushed into 60 meshes, and the first reflux extraction is carried out with pure water at a solid-liquid ratio of 1:6-10 for 20-40 minutes, and the first filtrate is obtained by filtering, and the second filtrate is obtained by adding pure water at a solid-liquid ratio of 1:6-8 for a second reflux extraction for 20-40 minutes, and the second filtrate is obtained by filtering, and the two filtrates are combined and concentrated to a paste under reduced pressure, and finally freeze-dried and ground into powder to obtain an American cockroach extract.
[0075] Take chrysanthemum and dendrobium, dry and grind them into 60 mesh, carry out the first reflux extraction for 20 to 40 minutes with pure water at a solid-liquid ratio of 1:6 to 10, filter to obtain the first filtrate, add pure water at a solid-liquid ratio of 1:6 to 8, carry out the second reflux extraction for 20 to 40 minutes, filter to obtain the second filtrate, combine the two filtrates, concentrate them under reduced pressure to a paste, and finally freeze-dry and grind them into powder to obtain chrysanthemum extract and dendrobium extract.
[0076] According to the weight ratio, 10-20 parts of the above-mentioned coptis extract, 24-48 parts of astragalus extract, 10-20 parts of American cockroach extract, 20-40 parts of chrysanthemum extract, and 10-20 parts of dendrobium extract are mixed evenly to obtain a coptis Chinese medicine composition. The preferred formula is 5g of coptis extract, 12g of astragalus extract, 5g of American cockroach extract, 10g of chrysanthemum extract, and 5g of dendrobium extract.
[0077] In order to control the content of the active ingredients in the above-mentioned Chinese herbal medicine composition of Coptis chinensis, that is, to control the content of calycosin isoflavone glucoside to be ≥0.080%, the content of calycosin isoflavone to be ≥0.030%, the content of berberine hydrochloride to be ≥0.080%, and the content of bamipine hydrochloride to be ≥0.110% in the Chinese herbal medicine composition of Coptis chinensis, the specific process of the quality control method provided by the present invention can be summarized as follows:
[0078] First, a test solution and a reference solution of the Rhizoma Coptidis Chinese medicine composition are prepared, wherein:
[0079] Preparation of test solution: Take 0.5g of the Chinese medicinal composition of Coptis chinensis, add 25ml of 50% methanol-hydrochloric acid, control the power to 300w, and the frequency to 50kHz for ultrasonic treatment for 30min, and obtain the solution;
[0080] Preparation of reference solution: Take calysin glucoside, palmatine hydrochloride, berberine hydrochloride, and calysin isoflavone, add methanol to prepare a mixed solution containing 10 μg of calysin glucoside, 40 μg of palmatine hydrochloride, 180 μg of berberine hydrochloride, and 40 μg of calysin isoflavone per 1 ml.
[0081] Then, the test solution and the reference solution were respectively subjected to high performance liquid chromatography detection to obtain corresponding characteristic spectra. During the high performance liquid chromatography detection, a C18 chromatographic column was used; acetonitrile was used as mobile phase A, and 0.2% phosphoric acid solution was used as mobile phase B, and gradient elution was performed; the flow rate was 1.0 ml / min; the detection wavelength was 260 nm; and the column temperature was 25°C.
[0082] The gradient elution process is as follows:
[0083] 0-15min, mobile phase A: 10%→20%, mobile phase B: 90%→80%;
[0084] 15-30 min, mobile phase A: 20% → 30%, mobile phase B: 80% → 70%;
[0085] 30-50 min, mobile phase A: 30%→50%, mobile phase B: 70%→50%.
[0086] Furthermore, the characteristic spectrum of the reference solution is used as a reference spectrum to construct the characteristic spectrum of the Coptis chinensis Chinese medicine composition. Finally, the characteristic peaks of the characteristic spectrum of the Coptis chinensis Chinese medicine composition are used as the quality control standard of the Coptis chinensis Chinese medicine composition to achieve the content control of specific effective ingredients (calycosin isoflavone glucoside, calycosin isoflavone, berberine hydrochloride, bamipine hydrochloride) in the Coptis chinensis Chinese medicine composition.
[0087] The present invention is further described in detail below in conjunction with examples, but the embodiments of the present invention are not limited thereto.
[0088] The instruments and reagents involved in the embodiments of the present invention are as follows:
[0089] 1. Instrument
[0090] Chromatograph: Agilent 1260 InfinityⅡ chromatography system (including G711A quaternary pump, G7115A DAD detector);
[0091] Column 1: Agilent Eclipse XDB-C18 column (250 mm × 4.6 mm, 5 μm);
[0092] Column 2: Waters Symmetry C18 column (250 mm × 4.6 mm, 5 μm);
[0093] Column 3: Agilent ZORBAX SB-C18 column (250 mm × 4.6 mm, 5 μm);
[0094] Others: SQP electronic balance, DHG-9245A electric constant temperature air drying oven, FD-1A-50 freeze dryer, Milli-QIQ 7000 water purifier, XM-P101H ultrasonic cleaner.
[0095] 2. Reagents
[0096] Acetonitrile was chromatographically pure, water was Wahaha water; other reagents were of analytical grade;
[0097] Calycosin (Chengdu Pusi Biotechnology Co., Ltd.: PS10251, purity: 98.0%);
[0098] Isoflavone glucoside (China Food and Drug Administration: 111920-201907, purity: 96.8%);
[0099] Bamipine hydrochloride (China Food and Drug Inspection Institute: 110732-201108, purity: 86.2%);
[0100] Berberine hydrochloride (China Food and Drug Inspection Institute: 110713-202316, purity: 91.0%).
[0101] Example 1: Determination of different preparation processes of Coptis chinensis Chinese medicine composition
[0102] 5g of Coptis chinensis, 12g of Astragalus membranaceus, 5g of American cockroach, 10g of Cyperus rotundus and 5g of Dendrobium officinale were respectively taken and mixed to obtain the formula raw materials, and then the corresponding Coptis chinensis traditional Chinese medicine composition was prepared according to the pure water reflux extraction and 70% ethanol reflux extraction processes respectively.
[0103] Pure water reflux extraction: Take 37g of the Coptis chinensis formula, add 8 times the amount of pure water, reflux extraction for 30 minutes, filter, then add 6 times the amount of pure water, reflux extraction for 30 minutes, combine the two filtrates, concentrate under reduced pressure and then vacuum dry to obtain the water extract of the Coptis chinensis formula. The total amount of the extract is 7.41g, and the extraction rate is 20.03%.
[0104] 70% ethanol reflux extraction: Take 37g of the Coptis chinensis formula, add 8 times the amount of 70% ethanol, reflux extraction for 30 minutes, filter, then add 6 times the amount of 70% ethanol, reflux extraction for 30 minutes, combine the two filtrates, concentrate under reduced pressure and then vacuum dry to obtain the alcohol extract of the Coptis chinensis formula. The total amount of the extract is 6.66g, and the extraction rate is 18.00%.
[0105] Based on the above-mentioned water extract and alcohol extract of the Coptis chinensis formula, the contents of the effective ingredients (calycosin glucoside, calycosin, berberine hydrochloride, and bamipine hydrochloride) in the corresponding extracts were detected.
[0106] The specific detection methods are as follows:
[0107] Chromatographic conditions: Agilent Eclipse XDB-C18 column (250 mm × 4.6 mm, 5 μm), acetonitrile as mobile phase A, 0.2% phosphoric acid solution as mobile phase B, gradient elution according to the following table; flow rate 1.0 ml / min; detection wavelength 260 nm; column temperature 25 ° C,
[0108] The gradient elution process is as follows:
[0109] 0-15min, mobile phase A: 10%→20%, mobile phase B: 90%→80%;
[0110] 15-30 min, mobile phase A: 20% → 30%, mobile phase B: 80% → 70%;
[0111] 30-50 min, mobile phase A: 30%→50%, mobile phase B: 70%→50%.
[0112] Preparation of reference solution: Take appropriate amount of calycosin glucoside, palmatine hydrochloride, berberine hydrochloride, and calycosin reference substance, accurately weigh, and add methanol to prepare a mixed reference solution containing 10 μg of calycosin glucoside, 40 μg of palmatine hydrochloride, 180 μg of berberine hydrochloride, and 40 μg of calycosin per 1 ml.
[0113] Preparation of test solution: Take 0.5g of the extract of the Rhizoma Coptidis, weigh it accurately, put it in a stoppered conical bottle, add 25ml of 50% methanol-hydrochloric acid (100:1), stopper it tightly, weigh it, treat it with ultrasound (power 300w, frequency 50kHz) for 30 minutes, let it cool, weigh it again, make up the lost weight with 50% methanol, shake it well, filter it, and you have it.
[0114] Determination method: Accurately pipette 10μl of the test solution and the reference solution, inject into the liquid chromatograph, and determine.
[0115] The liquid chromatography of blank solution, mixed reference solution, water extract of Rhizoma Coptidis and alcohol extract of Rhizoma Coptidis was determined as follows: Figures 1 to 4 As shown, the corresponding peak areas of calycosin glucoside, palmatine hydrochloride, berberine hydrochloride and calycosin in the chromatogram are calculated as shown in Table 1.
[0116] Table 1 Chromatographic parameters of standard products and samples of Rhizoma Coptidis formula
[0117]
[0118] The HPLC fingerprints of water extract and alcohol extract of Rhizoma Coptidis were analyzed using the Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System (2012 Edition). Figure 5 As shown, S1 was used as the reference spectrum (using the median method, with a time window width of 0.2 min), and full peak matching was performed. The similarity was calculated using the control fingerprint spectrum as a reference. The similarity is shown in Table 2 below. The HPLC fingerprints of the water extract and the alcohol extract of the Rhizoma Coptidis formula are similar in fingerprint characteristics and composition, with a similarity of >0.900. However, the contents of their main components are different, so it is necessary to clarify the contents of the main components of the monarch drug Astragalus and Rhizoma Coptidis in the Rhizoma Coptidis formula.
[0119] Table 2 Similarity of fingerprints of water extract of Rhizoma Coptidis and alcohol extract of Rhizoma Coptidis
[0120] S1 Coptis chinensis water extract S2 Coptis chinensis formula ethanol extract Comparison fingerprint S1 Coptis chinensis water extract 1.000 0.909 0.964 S2 Coptis chinensis formula ethanol extract 0.909 1.000 0.987 Comparison fingerprint 0.964 0.987 1.000
[0121] (1) Determination of the contents of epiberberine, coptisine, palmatine and berberine in the Rhizoma Coptidis formula
[0122] Three batches of water extracts and alcohol extracts of Rhizoma Coptidis were tested, and the results are shown in Tables 3 to 6. The test results show that the contents of epiberberine, coptisine, palmatine and berberine in the alcohol extract of Rhizoma Coptidis are higher than those in the water extract.
[0123] Table 3. Determination results of berberine
[0124]
[0125] Table 4 The determination results of coptisine
[0126]
[0127]
[0128] Table 5 The determination results of Bamipine
[0129]
[0130] Table 6 Determination results of berberine
[0131]
[0132]
[0133] (2) Determination of the content of calycosin glucoside and calycosin in the Huanglian formula
[0134] Three batches of water extracts and alcohol extracts of Rhizoma Coptidis were tested, and the results are shown in Tables 7 and 8. The test results show that the content of calycosin glucoside in the alcohol extract of Rhizoma Coptidis is higher than that in the water extract, and the content of calycosin isoflavone is lower than that in the water extract.
[0135] Table 7 Determination results of calycosin isoflavone glucoside
[0136]
[0137] Table 8 The determination results of calycosin isoflavone
[0138]
[0139]
[0140] In summary, the HPLC fingerprints of the water extract and the alcohol extract of the Rhizoma Coptidis formula showed that the fingerprint characteristics of the water extract and the alcohol extract of the Rhizoma Coptidis formula were similar, the components were similar, and the similarity was greater than 0.900, but the contents of the main components were different. Therefore, their contents were further determined. The results showed that the average contents of epiberberine, coptisine, palmatine, berberine, calycosin glucoside, and calycosin in the alcohol extract of the Rhizoma Coptidis formula were 0.131%, 0.204%, 0.316%, and 1. The average contents of epiberberine, coptisine, bamipine, berberine, calycosin glucoside and calycosin in the water extract of Rhizoma Coptidis were 192%, 0.115% and 0.020%, respectively. Except for the content of calycosin, the contents of epiberberine, coptisine, bamipine, berberine and calycosin glucoside in the alcohol extract of Rhizoma Coptidis were significantly higher than those in the water extract.
[0141] Further combined with the above-mentioned extraction rate of water extract of Coptis chinensis formula is 20.03%, and the extraction rate of alcohol extract of Coptis chinensis formula is 18.00%, it is determined that the monarch drugs Coptis chinensis and Astragalus membranaceus in the Coptis chinensis formula are extracted with alcohol; the auxiliary drug American cockroach and the adjuvant drugs Acanthopanax odoratus and Dendrobium candidum are extracted with water.
[0142] Example 2: Investigation process of detection method
[0143] This example relates to an investigation of the method for detecting the contents of calycosin glucoside, calycosin, berberine hydrochloride, and bamipine hydrochloride in the Chinese medicine composition of Coptis chinensis in Example 1, and specifically to an investigation of the preparation of the test solution.
[0144] (1) The extraction effects of different solvent systems, 50% methanol and 50% methanol-hydrochloric acid (100:1), on the aqueous and alcohol extracts of the Rhizoma Coptidis formula were investigated. The results are shown in Figures 6 to 9 , as shown in Tables 9 and 10.
[0145] The results showed that the two extraction solvents (water extract of Coptis chinensis formula and alcohol extract of Coptis chinensis formula) had the best extraction effect in 50% methanol-hydrochloric acid (100:1), so 50% methanol-hydrochloric acid (100:1) system was initially selected as the extraction solvent.
[0146] Table 9 Chromatographic parameters of water extract of Rhizoma Coptidis formula
[0147]
[0148]
[0149] Table 10 Chromatographic parameters of ethanol extract of Rhizoma Coptidis formula
[0150]
[0151] (2) The extraction effects of different solvents (methanol-hydrochloric acid (100:1), 50% methanol-hydrochloric acid (100:1), and 30% methanol-hydrochloric acid (100:1) on the aqueous and alcohol extracts of the Rhizoma Coptidis formula were investigated. The results are shown in Figures 10 to 15 , as shown in Table 11 and Table 12.
[0152] Based on the information of chromatographic peak shape, peak area, etc., it was found that the extraction effect was best in 50% methanol-hydrochloric acid (100:1) solvent, so 50% methanol-hydrochloric acid (100:1) was selected as the extraction solvent.
[0153] Table 11 Chromatographic parameters of water extract of Rhizoma Coptidis formula
[0154]
[0155] Table 12 Chromatographic parameters of ethanol extract of Rhizoma Coptidis formula
[0156]
[0157]
[0158] Example 3: Detection method of Coptis chinensis
[0159] This embodiment relates to a method for detecting the contents of epiberberine, coptisine, palmatine and berberine in the Coptis chinensis Chinese medicine composition in Example 1.
[0160] Octadecylsilane bonded silica gel is used as filler; acetonitrile-0.05 mol / L potassium dihydrogen phosphate solution (50:50) (0.4 g of sodium dodecyl sulfate is added to every 100 ml, and the pH value is adjusted to 4.0 with phosphoric acid) is used as mobile phase; the detection wavelength is 345 nm. The theoretical plate number calculated based on the berberine hydrochloride peak should not be less than 5000.
[0161] Preparation of reference solution: Take an appropriate amount of berberine hydrochloride reference substance, weigh it accurately, and add methanol to make a solution containing 100 μg per 1 ml.
[0162] Preparation of test solution: Take about 0.2 g of the powder of the product, weigh it accurately, put it in a stoppered conical flask, accurately add 25 ml of a mixed solution of 50% methanol-hydrochloric acid (100:1), stopper it tightly, weigh it, ultrasonically treat it (power 250 W, frequency 40 kHz) for 30 minutes, cool it, weigh it again, make up the lost weight with 50% methanol, shake it well, filter it, and take the filtrate to obtain the solution.
[0163] Determination method: Accurately pipette 10 μl of reference solution and test solution respectively, inject into liquid chromatograph and determine.
[0164] Using the peak area of berberine hydrochloride reference substance as reference, calculate the contents of berberine, epiberberine, coptisine and palmatine respectively, and determine them by the relative retention time of the chromatographic peak of the component to be tested and the chromatographic peak of berberine hydrochloride. The peak positions of epiberberine, coptisine, palmatine and berberine, and their relative retention times should be within the range of ±5% of the specified value.
[0165] The detection method described in this example was verified by chromatographic conditions and system suitability, extraction solvent selection, methodology verification: specificity investigation, linear relationship investigation, precision test, repeatability investigation, intermediate precision investigation, stability test, and durability investigation (durability investigation at different flow rates, durability investigation at different column temperatures, and durability investigation at different chromatographic columns). It was shown that the method met the requirements for content determination and can be used to determine the contents of berberine, coptisine, bamipine, and berberine in the Coptis chinensis formula.
[0166] Embodiment 4: Astragalus detection method
[0167] This embodiment relates to a method for detecting the contents of calycosin glucoside and calycosin in the Astragalus of the Coptis chinensis Chinese medicine composition in Example 1 and an investigation of the method.
[0168] Octadecylsilane bonded silica gel was used as filler; acetonitrile was used as mobile phase A, 0.2% formic acid solution was used as mobile phase B, and gradient elution was performed according to the following process; the flow rate was 1.0 ml per minute; the detection wavelength was 260 nm; and the column temperature was 25°C.
[0169] 0-17min, mobile phase A: 16%, mobile phase B: 84%;
[0170] 17-18 min, mobile phase A: 16% → 32%, mobile phase B: 84% → 68%;
[0171] 18-30min, mobile phase A: 32%, mobile phase B: 68%.
[0172] Preparation of reference solution: Take appropriate amount of calycosin glucoside and calycosin reference, weigh accurately, add methanol to prepare a mixed solution containing 10 μg of calycosin glucoside and 4 μg of calycosin per 1 ml.
[0173] Preparation of test solution: Take about 0.5 g of the powder of the product, weigh it accurately, put it in a stoppered conical flask, add 25 ml of 50% methanol solution accurately, stopper it, weigh it, ultrasonically treat it (power 250 W, frequency 40 kHz) for 30 minutes, cool it, weigh it again, make up the lost weight with 50% methanol, shake it well, filter it, and take the filtrate to obtain it.
[0174] Determination method: Accurately pipette 10 μl of reference solution and test solution respectively, inject into liquid chromatograph and determine.
[0175] The detection method described in this embodiment was verified by chromatographic conditions and system suitability, extraction solvent selection, methodology verification: specificity investigation, linear relationship investigation, precision test, repeatability investigation, intermediate precision investigation, stability test, durability investigation (durability investigation at different flow rates, durability investigation at different column temperatures, and durability investigation at different chromatographic columns). It was shown that the method met the requirements for content determination and can be used to determine the contents of calycosin glucoside and calycosin in the Astragalus membranaceus formula.
[0176] Example 5: Chinese herbal medicine composition of Coptis chinensis and its preparation process
[0177] Based on the content of Example 1, the preparation process of the Chinese medicine composition of Coptis chinensis in this example is determined as follows:
[0178] Take the rhizome of Coptis chinensis, dry and crush it into 60 mesh, add 70% ethanol, and extract it in a water bath at 50°C for 2 hours with a solid-liquid ratio of 1:10, extract it twice, combine the extracts and concentrate them under reduced pressure to a paste, finally freeze-dry and grind them into powder to obtain the Coptis chinensis extract.
[0179] Take the rhizome of Astragalus, dry and crush it into 60 mesh, add 70% ethanol, and extract it in a water bath at 50°C for 1 hour with a solid-liquid ratio of 1:15, and extract it twice. After combining the extracts, concentrate them under reduced pressure to a paste, and finally freeze-dry them and grind them into powder to obtain the Astragalus extract.
[0180] Take American cockroach, dry and crush to 60 mesh, carry out the first reflux extraction for 20 minutes with pure water at a solid-liquid ratio of 1:6, filter to obtain the first filtrate, add pure water at a solid-liquid ratio of 1:6 for the second reflux extraction for 20 minutes, filter to obtain the second filtrate, combine the two filtrates and concentrate them under reduced pressure to a paste, finally freeze-dry and grind into powder to obtain an American cockroach extract.
[0181] Take the chrysanthemum and dendrobium, dry and grind them into 60 mesh, carry out the first reflux extraction for 20 minutes with pure water at a solid-liquid ratio of 1:6, filter to obtain the first filtrate, add pure water at a solid-liquid ratio of 1:6 for a second reflux extraction for 20 minutes, filter to obtain the second filtrate, combine the two filtrates and concentrate them under reduced pressure to a paste, finally freeze-dry and grind them into powder to obtain the chrysanthemum extract and the dendrobium extract.
[0182] Take 5 g of the above-mentioned Coptis chinensis extract, 12 g of Astragalus membranaceus extract, 5 g of American cockroach extract, 10 g of Acanthopanax odoratus extract, and 5 g of Dendrobium officinale extract and mix them evenly to obtain Coptis chinensis Chinese medicine composition 1#.
[0183] Example 6: Chinese herbal medicine composition of Coptis chinensis and its preparation process
[0184] Based on the content of Example 1, the preparation process of the Chinese medicine composition of Coptis chinensis in this example is determined as follows:
[0185] Take the rhizome of Coptis chinensis, dry and crush it into 60 mesh, add 70% ethanol, and extract it in a water bath at 55°C for 3 hours with a solid-liquid ratio of 1:15, extract it twice, combine the extracts and concentrate them under reduced pressure to a paste, finally freeze-dry and grind them into powder to obtain the Coptis chinensis extract.
[0186] Take the rhizome of Astragalus, dry and crush it into 60 mesh, add 70% ethanol, and extract it in a water bath at 60°C for 2 hours with a solid-liquid ratio of 1:20. Extract it twice, combine the extracts and concentrate them under reduced pressure to a paste, finally freeze-dry and grind them into powder to obtain Astragalus extract.
[0187] Take American cockroaches, dry and crush them into 60 meshes, perform the first reflux extraction for 40 minutes with pure water at a solid-liquid ratio of 1:6, filter to obtain the first filtrate, add pure water at a solid-liquid ratio of 1:8 to perform the second reflux extraction for 40 minutes, filter to obtain the second filtrate, combine the two filtrates and concentrate them under reduced pressure to a paste, finally freeze-dry and grind them into powder to obtain an American cockroach extract.
[0188] Take the chrysanthemum and dendrobium, dry and grind them into 60 mesh, carry out the first reflux extraction for 35 minutes with pure water at a solid-liquid ratio of 1:8, filter to obtain the first filtrate, add pure water at a solid-liquid ratio of 1:6 for a second reflux extraction for 35 minutes, filter to obtain the second filtrate, combine the two filtrates and concentrate them under reduced pressure to a paste, finally freeze-dry and grind them into powder to obtain the chrysanthemum extract and the dendrobium extract.
[0189] Take 5 g of the above-mentioned Coptis chinensis extract, 12 g of Astragalus membranaceus extract, 5 g of American cockroach extract, 10 g of Acanthopanax odoratus extract, and 5 g of Dendrobium officinale extract and mix them evenly to obtain Coptis chinensis Chinese medicine composition 2#.
[0190] Example 7: Chinese herbal medicine composition of Coptis chinensis and its preparation process
[0191] Based on the content of Example 1, the preparation process of the Chinese medicine composition of Coptis chinensis in this example is determined as follows:
[0192] Take the rhizome of Coptis chinensis, dry and crush it into 60 mesh, add 70% ethanol, and extract it in a water bath at 60°C for 3 hours with a solid-liquid ratio of 1:12, extract it twice, combine the extracts and concentrate them under reduced pressure to a paste, finally freeze-dry and grind them into powder to obtain the Coptis chinensis extract.
[0193] Take the rhizome of Astragalus, dry and crush it into 60 mesh, add 70% ethanol, and extract it in a water bath at 60°C for 2 hours with a solid-liquid ratio of 1:20. Extract it twice, combine the extracts and concentrate them under reduced pressure to a paste, finally freeze-dry and grind them into powder to obtain Astragalus extract.
[0194] Take American cockroaches, dry and crush them into 60 meshes, perform the first reflux extraction for 40 minutes with pure water at a solid-liquid ratio of 1:10, filter to obtain the first filtrate, add pure water at a solid-liquid ratio of 1:8 for the second reflux extraction for 40 minutes, filter to obtain the second filtrate, combine the two filtrates and concentrate them under reduced pressure to a paste, finally freeze-dry and grind them into powder to obtain an American cockroach extract.
[0195] Take the chrysanthemum and dendrobium, dry and grind them into 60 mesh, carry out the first reflux extraction for 40 minutes with pure water at a solid-liquid ratio of 1:10, filter to obtain the first filtrate, add pure water at a solid-liquid ratio of 1:8 for a second reflux extraction for 40 minutes, filter to obtain the second filtrate, combine the two filtrates and concentrate them under reduced pressure to a paste, finally freeze-dry and grind them into powder to obtain the chrysanthemum extract and dendrobium extract.
[0196] Take 5g of the above-mentioned Coptis chinensis extract, 12g of Astragalus membranaceus extract, 5g of American cockroach extract, 10g of Acanthopanax rutaecarpa extract, and 5g of Dendrobium officinale extract and mix them evenly to obtain Coptis chinensis Chinese medicine composition 3#.
[0197] Comparative Example 1:
[0198] Prepare coptis chinensis extract and astragalus extract respectively according to the method of Example 6, then take 5 g of the prepared coptis chinensis extract and 12 g of astragalus extract respectively, mix them evenly, and obtain control Chinese medicine composition 1#.
[0199] Comparative Example 2:
[0200] Prepare coptis chinensis extract, astragalus extract and american cockroach extract respectively according to the method of Example 6, then take 5g of the prepared coptis chinensis extract, 12g of astragalus extract and 5g of american cockroach extract respectively, mix them evenly, and obtain control Chinese medicine composition 2#.
[0201] Comparative Example 3:
[0202] Prepare coptis chinensis extract, astragalus extract, chrysanthemum foetida extract and dendrobium extract respectively according to the method of Example 6, then take 5g of the prepared coptis chinensis extract, 12g of astragalus extract, 10g of chrysanthemum foetida extract and 5g of dendrobium extract respectively, mix them evenly, and obtain control Chinese medicine composition 3#.
[0203] The contents of calycosin glucoside, bamipine hydrochloride, berberine hydrochloride and calycosin in the Coptis chinensis Chinese medicine compositions 1# to 3# in Examples 5 to 7, and the control Chinese medicine compositions 1# to 3# in Comparative Examples 1 to 3 were determined, and the results are shown in Table 13 below.
[0204] Table 13 Comparison of the active ingredient content of Example 1 and Comparative Example 1
[0205] Example 5 Example 6 Example 7 Comparative Example 1 Comparative Example 2 Comparative Example 3 Isoflavone Glucoside 0.121 0.142 0.133 0.112 0.112 0.136 Bamipine Hydrochloride 0.300 0.380 0.320 0.280 0.282 0.360 Berberine Hydrochloride 1.18 1.48 1.32 1.08 1.10 1.36 Isoflavone 0.018 0.024 0.021 0.014 0.014 0.021
[0206] As can be seen from the above table, the Rhizoma Coptidis Chinese medicine composition prepared by the formula and preparation process of the present invention can significantly increase the overall content of its main effective ingredients, namely, calycosin glucoside, palmatine hydrochloride, berberine hydrochloride and calycosin isoflavones.
[0207] Example 8: Clinical Trial
[0208] The Coptis chinensis Chinese medicine composition 1# of the above-mentioned Example 5 and the control Chinese medicine composition 3# of Comparative Example 3 were selected for clinical experiments.
[0209] Patient inclusion criteria: (1) Chronic: yellow-white ulcer spots in the oral cavity, followed by the formation of superficial ulcers, elliptical or round in shape, with a diameter of less than 5 mm. (2) Acute: Diameter > 1 cm, redness, swelling and slight bulge of the tissue around the ulcer, slightly hard base, with gray-yellow pseudomembrane or gray-white necrotic tissue on the surface.
[0210] A total of 278 patients who met the inclusion criteria were divided into a treatment group (50 patients with chronic oral ulcers and 48 patients with acute oral ulcers), a control group (50 patients with chronic oral ulcers and 40 patients with acute oral ulcers) and a blank group (50 patients with chronic oral ulcers and 40 patients with acute oral ulcers). The treatment group was treated with Coptis chinensis Chinese medicine composition 1#, the control group was treated with control Chinese medicine composition 3#, and the blank group was treated with a placebo.
[0211] Oral ulcer treatment score: The main characteristics include ulcer size, ulcer pain, ulcer number, ulcer congestion, and burning sensation. Ulcer size: 0 points for no ulcer, 1 point for ulcer diameter ≤5 mm, 2 points for ulcer diameter 5-10 mm, and 3 points for ulcer diameter ≥1 cm; ulcer pain: 0 points for no pain, 1 point for mild pain, 2 points for slightly obvious pain but not affecting eating, and 3 points for obvious pain affecting eating; ulcer number: 0 points for no ulcer, 1 point for 2-3 ulcers, 2 points for 3-5 ulcers, and 3 points for 5 ulcers; ulcer congestion: 0 points for no congestion, 1 point for slightly red ulcers, 2 points for dark red ulcers, and 3 points for purple ulcers; burning sensation: 0 points for no burning sensation, 1 point for slight burning sensation, 2 points for obvious burning sensation, and 3 points for unbearable burning sensation.
[0212] The treatment results (same treatment cycle) are shown in Table 14 below.
[0213] Table 14 Treatment effect of oral ulcer in treatment group and comparison treatment group
[0214]
[0215] Combined with the patient treatment results, it can be seen that compared with the blank group, the treatment group and the control treatment group showed significant improvement in chronic oral ulcers and acute oral ulcers after being treated with Coptis chinensis Chinese medicine composition 1# and control Chinese medicine composition 3#, respectively.
[0216] Comparing the therapeutic effects between the treatment group and the control group, the ulcer size of patients with chronic oral ulcers in the treatment group was significantly reduced, there was a slight burning sensation, a little ulcer pain but not obvious, the number of ulcers was significantly reduced, most of them had no ulcers, a few had one or so ulcers, and the overall therapeutic effect was significantly better than that of the control group; the ulcer size of patients with acute oral ulcers in the treatment group was significantly reduced, there was a slight burning sensation, a little ulcer pain but not obvious, the number of ulcers was significantly reduced, there were only one or two ulcers, and most patients had recovered, and the overall therapeutic effect was also significantly better than that of the control group.
[0217] Further combined with the data in Table 13 and Table 14 above, it can be seen that although the control Chinese medicine composition 3# in Comparative Example 3 did not add American cockroach or its extract, the content of its effective ingredients, calycosin glucoside, bamipine hydrochloride, berberine hydrochloride, and calycosin isoflavones, is not much different from the content of the effective ingredients of the Chinese medicine formula of the present invention, and the content of the effective ingredient of the control Chinese medicine composition 3# is slightly higher than that of the Coptis chinensis Chinese medicine composition 1# in Example 5. This is because the active ingredient provided by American cockroach or its extract is a polypeptide substance. However, the therapeutic effect of the control Chinese medicine composition 3# without adding American cockroach or its extract is significantly lower than that of the Coptis chinensis Chinese medicine composition 1# of Example 5. The reason is that American cockroach or its extract, as the auxiliary medicine of the main medicine Coptis chinensis and Astragalus membranaceus, can enhance the therapeutic effect of the effective ingredients on patients. Therefore, the Chinese medicine prescription of Coptis chinensis, Astragalus membranaceus, American cockroach, Acanthopanax odoratus, and Dendrobium officinale in the present invention has a good therapeutic effect on acute and chronic oral ulcers, and also has a good therapeutic effect on gum problems caused by the same reason.
[0218] Example 9: Animal Experiment
[0219] This example further verifies the relevance of the Chinese medicine composition of the present invention to in vivo cytokines related to recurrent oral ulcer (RAU) through animal experiments.
[0220] 1. Materials and Methods
[0221] Experimental animals: 52 6-week-old SD rats (180-220 g), male, SPF grade (Beijing Sibeifu Biotechnology Co., Ltd.), production license number: SCXK (Beijing) 2019-0010, breeding conditions: room temperature (22 ± 2) ° C, humidity (50 ± 10)%, unlimited food and water.
[0222] Drugs and reagents: Rhizoma Coptidis formula (Rhizoma Coptidis Chinese medicine composition 2#), prednisone acetate, glacial acetic acid, ELISA kit (Nanjing Jiancheng Bioengineering Institute, Xinbosheng Biotechnology Co., Ltd.), hematoxylin and eosin staining solution (Wuhan Sewell Biotechnology Co., Ltd.)
[0223] Methods: Rats were randomly divided into a normal group (4 rats, and 6 rats in each of the other groups), a model group, a positive control group, and low-dose, medium-dose, and high-dose groups of the Rhizoma Coptidis. The RAU model was established by chemical burning in all rats except the normal group. The specific method was as follows: SD rats were anesthetized with 10% chloral hydrate, and filter paper (5 mm in diameter) soaked in 50% acetic acid was used to induce ulcers, which were then placed on the inner mucosa of the lips for 1 minute, and then the filter paper was removed. Two days after modeling, except for the normal group, the RAU model was successfully established in the model group, the positive control group, the high-dose, medium-dose, and low-dose Rhizoma Coptidis groups.
[0224] Administration: Rats in the positive control group were given prednisone acetate (125 mg / kg) by gavage, and rats in the low-dose group (A, B), medium-dose group (C, D) and high-dose group (E, F) of the Coptis chinensis formula were given the Coptis chinensis formula (A, B: 0.1g / kg, 0.2g / kg, C, D: 0.4g / kg, 0.8g / kg, E, F: 1.6g / kg, 3.2g / kg) by gavage, once a day for 20 days.
[0225] The experimental results are as follows:
[0226] (1) Effects of the Rhizoma Coptidis formula on the oral cavity of rats
[0227] The conditions of the rats were observed and recorded, and the oral ulcer areas of the rats were measured one day before administration and 5, 10, 15, and 20 days after administration, and the average values were taken.
[0228] As of the day of sampling, except for the normal group, all the rats in the other groups had oral ulcers. The ulcer surface was irregular, covered with white pseudomembrane, and the surrounding mucosa was red, swollen and congested. The oral ulcers of the rats in the positive control group, high-dose group, medium-dose group and low-dose group of Coptis chinensis formula were improved to a certain extent, and the ulcer surface was reduced. Fig.16 and Fig.17 shown.
[0229] Fig.16 Figure 2 shows the histological changes of oral mucosa of ROU rats (HE, 40 times magnification), where MODEL is the model group; PA is the positive drug group; low (A) is the low-dose group of Coptis chinensis prescription 0.1 g / kg; mid (C) is the medium-dose group of Coptis chinensis prescription 0.4 g / kg; high (E) is the high-dose group of Coptis chinensis prescription 1.6 g / kg; low (B) is the low-dose group of Coptis chinensis prescription 0.2 g / kg; mid (D) is the medium-dose group of Coptis chinensis prescription 0.8 g / kg; high (F) is the high-dose group of Coptis chinensis prescription 3.2 g / kg.
[0230] Depend on Fig.16 The HE staining results shown showed partial destruction of the oral mucosal epithelial tissue in the model group rats, in which the epithelial layer became thinner, the cells of the basal layer and the lamina propria showed irregular arrangement, and the number of inflammatory and fibroblast-like cells increased. After the ROU rats were treated with the corresponding drugs, the membrane repair of the epithelial mucosa was gradually observed, the cells of the basal layer and the lamina propria showed normal organization, and there were rare inflammatory cells around the blood vessels.
[0231] (2) ELISA kit detection
[0232] 2 hours after the last administration, the rats were anesthetized, blood was collected by abdominal aorta puncture, and serum was separated for ELISA kit detection. A standard curve was prepared according to the kit instructions to detect and calculate the levels of inflammatory factors IL-10, IL-17, TGF-β1, IL-1β, IL-2, TNF-α, EGF, IL-6, in the serum. For details, see Fig.18 shown.
[0233] Depend on Fig.18 As shown, TGF-β1 is a key factor in promoting wound healing, and IL-10 is an important immunosuppressive cytokine with anti-inflammatory effects, which can reduce inflammatory reactions. The results showed that compared with the model group, the positive drug group and each dose group of the Coptis chinensis formula could increase the level of TGF-β1 in rat serum, and the medium and high dose groups of the Coptis chinensis formula had a higher level of increase than the positive drug group; compared with the model group, the positive drug group and each dose group of the Coptis chinensis formula could increase the level of IL-10 in rat serum, but the level of increase in each dose group of the Coptis chinensis formula was not as good as that of the positive drug group.
[0234] IL-17 is an early initiator of T cell-induced inflammatory response, which can amplify inflammatory response by promoting the release of pro-inflammatory cytokines. The Rhizoma Coptidis formula has a tendency to reduce the level of IL-17 in rat serum; compared with the model group, the positive drug and the Rhizoma Coptidis formula concentration groups can reduce the level of pro-inflammatory cytokine IL-6 in rat serum, and the reduction level of the Rhizoma Coptidis formula dose groups is similar to that of the positive drug group.
[0235] (3) Pathological changes of ulcer tissues and relative expression of NLRP3 mRNA in rats in each group
[0236] After the blood was collected from the abdominal aorta, the tissues in the oral ulcer area of each group of animals were separated, divided into tissue blocks of appropriate size and fixed for 48 hours, paraffin tissue specimens and pathological sections were made (the paraffin tissue blocks were placed on a slicer to make tissue sections with a thickness of 4 μm), and then routine HE staining was performed. After sealing, the oral mucosal lesions were observed under a light microscope. Realtime PCR was used to detect the relative expression of NLRP3 gene in the mucosal tissue of each group of rats. The specific steps were carried out according to "Real-time fluorescence quantitative PCR". For details, see Fig.19 shown.
[0237] Fig.19 This is the effect of the Coptis chinensis formula on the gene expression of NLRP3 transcription factor in RAU rats. As can be seen from the figure, compared with the model group, the NLRP3 gene expression level of the low-dose Coptis chinensis formula is similar, the gene expression level of the positive drug group and the medium and high-dose Coptis chinensis formula group is slightly lower, and the gene expression levels of the three are similar.
[0238] (4) Western blot was used to detect the expression of NF-κB inflammatory pathway proteins in the ulcer tissues of rats in each group
[0239] Oral mucosal tissue was taken, weighed, cut into pieces, added with cell lysis solution, ground and homogenized, and centrifuged. Tissue protein was extracted and the concentration was determined by BCA method. According to the protein amount of 20 μg / well, the sample was routinely loaded, electrophoresed, transferred and blocked. The transferred PVDF membrane was added to the primary antibody solution (1:2 000) and incubated at 4°C overnight. The membrane was washed the next day and placed in the secondary antibody solution (1:2 000) in a 37°C incubator for 2 hours. After washing again, an appropriate amount of luminescent reagent was added and placed in a gel imager for development. Image J software was used to obtain the gray value of the target protein and perform statistical analysis. For details, see Fig. 20 shown.
[0240] Fig. 20 This is the expression of NF-κBp65, p-IκBa and IKKα proteins in the oral mucosal tissue of rats. As can be seen from the figure, the levels of NF-κBp65, p-IκBa and IKKα proteins in the oral mucosal tissue of the model group, drug group and normal group decreased in turn.
[0241] In summary, the Rhizoma Coptidis formula can reduce the levels of serum inflammatory factors in RAU rats, increase the levels of serum anti-inflammatory factors and wound healing factors in rats, and may play a repairing role on oral ulcer mucosa by inhibiting the NF-κB inflammatory pathway.
[0242] Embodiment 10: Coptis chinensis toothpaste
[0243] The Coptis chinensis Chinese medicine composition 1# of Example 5 above is selected as the main raw material, and is mixed with an appropriate proportion of abrasives, humectants, thickeners, foaming agents, fragrances and water to prepare Coptis chinensis toothpaste. At the same time, the raw materials for toothpaste preparation should comply with relevant specifications, and the content determination index of Coptis chinensis extract in toothpaste should comply with the Coptis chinensis extract (in terms of berberine, epiberberine, coptisine, and bamipine) (mg / 100g) ≥ 1.5.
[0244] The method for determining the content of the Coptidis rhizome extract can refer to the Coptidis rhizome detection method in Example 3.
[0245] The sensory requirements, physical and chemical indicators, and hygiene indicators of the prepared Coptis chinensis toothpaste were tested (referring to standard GB / T8372), as shown in Tables 15 to 17 below.
[0246] Table 15 Sensory requirements
[0247]
[0248] Table 16 Physical and chemical indicators
[0249]
[0250] Table 17 Hygiene indicators
[0251]
[0252] Experiments have shown that the Rhizoma Coptidis toothpaste prepared in this embodiment meets the relevant standards of oral cleaning and care products (physical and chemical indicators, toxic substance limits, microbial indicators, etc.). At the same time, due to the addition of the Rhizoma Coptidis Chinese medicine composition, the Rhizoma Coptidis toothpaste has the relevant effects of treating acute and chronic oral ulcers and improving gum problems after use.
[0253] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. Any simple modification or equivalent change made to the above embodiment based on the technical essence of the present invention shall fall within the protection scope of the present invention.
Claims
1. A Chinese medicinal composition of Coptis chinensis, characterized in that: The active ingredients are coptis chinensis or its extract, astragalus or its extract, American cockroach or its extract, chrysanthemum or its extract, dendrobium or its extract, and the content of calycosin glucoside in the coptis chinensis Chinese medicine composition is controlled to be ≥0.080%, the content of calycosin isoflavone is ≥0.030%, the content of berberine hydrochloride is ≥0.080%, and the content of palmatine hydrochloride is ≥0.110%. In terms of weight, the composition comprises 10 to 20 parts of coptis chinensis or its extract, 24 to 48 parts of astragalus or its extract, 10 to 20 parts of american cockroach or its extract, 20 to 40 parts of chrysanthemum officinale or its extract, and 10 to 20 parts of dendrobium or its extract.
2. A preparation process of the Chinese medicine composition of Coptis chinensis as claimed in claim 1, characterized in that: At least the following operations are included: (1) Taking the rhizome of Coptis chinensis, drying and crushing it, adding ethanol, and then extracting it in a water bath, decompressing and concentrating the extract to a paste, and finally freeze-drying it and grinding it into powder to obtain a Coptis chinensis extract; (2) Taking the rhizome of Astragalus membranaceus, drying and crushing it, adding ethanol, and then extracting it in a water bath, decompressing and concentrating the extract to a paste, and finally freeze-drying it and grinding it into powder to obtain an Astragalus membranaceus extract; (3) taking an American cockroach, drying and crushing it, and then refluxing it with pure water, concentrating the extract under reduced pressure to a paste, and finally freeze-drying it and grinding it into powder to obtain an American cockroach extract; (4) taking chrysanthemum odoratum and dendrobium officinale according to a ratio, drying and crushing them, and then refluxing them with pure water, decompressing and concentrating the extract to a paste, and finally freeze-drying and grinding them into powder to obtain chrysanthemum odoratum extract and dendrobium officinale extract; (5) The above extracts are mixed according to the ratio to obtain a Chinese herbal medicine composition of Coptis chinensis.
3. The preparation process according to claim 2, characterized in that: In the operation (1), the rhizome of Coptis chinensis is dried and crushed into 60 mesh, 60-80% ethanol is added, and the mixture is extracted in a water bath at 50-60° C. for 2-3 hours at a solid-liquid ratio of 1:10-15, and the extraction is repeated twice. The extracts are combined and then concentrated under reduced pressure.
4. The preparation process according to claim 2, characterized in that: In the operation (2), the rhizome of Astragalus membranaceus is dried and crushed into 60 mesh, 70-80% ethanol is added, and the mixture is extracted in a water bath at 50-60°C for 1-2 hours at a solid-liquid ratio of 1:15-20, and the extraction is repeated twice. The extracts are combined and then concentrated under reduced pressure.
5. The preparation process according to claim 2, characterized in that: In the operations (3) and (4), the American cockroach is dried and crushed to 60 mesh, and the ophiopogon and dendrobium are dried and crushed to 60 mesh; the reflux extraction comprises performing a first reflux extraction for 20 to 40 minutes with pure water at a solid-liquid ratio of 1:6 to 10, filtering to obtain a first filtrate, adding pure water at a solid-liquid ratio of 1:6 to 8 for a second reflux extraction for 20 to 40 minutes, filtering to obtain a second filtrate, and combining the two filtrates for reduced pressure concentration.
6. A quality control method for the Coptidis rhizome Chinese medicine composition as claimed in claim 1, characterized in that: The following steps are involved: S1. Prepare a test solution and a reference solution of a Chinese medicinal composition of Coptis chinensis; S2. The test solution and the reference solution were subjected to HPLC to obtain the corresponding characteristic spectrum, and then the characteristic spectrum of the reference solution was used as a reference spectrum to construct a characteristic spectrum of the Chinese medicine composition of Coptis chinensis; S3. The characteristic peaks of the characteristic spectrum of the Coptis chinensis Chinese medicine composition are used as the quality control standard of the Coptis chinensis Chinese medicine composition.
7. The quality control method according to claim 6, characterized in that: In the step S1, 0.5 g of the Chinese medicinal composition of Coptis chinensis is taken, 25 ml of 50% methanol-hydrochloric acid is added, and the power is controlled to 300 W and the frequency is controlled to 50 kHz for ultrasonic treatment for 30 min to obtain a test solution.
8. The quality control method according to claim 6, characterized in that: In the step S1, take calysin glucoside, palmatine hydrochloride, berberine hydrochloride, and calysin glucoside, add methanol to prepare a mixed solution containing 10 µg of calysin glucoside, 40 µg of palmatine hydrochloride, 180 µg of berberine hydrochloride, and 40 µg of calysin glucoside per 1 ml, to obtain a reference solution.
9. The quality control method according to claim 6, characterized in that: In step S2, during the high performance liquid chromatography detection, a C18 chromatographic column was used; acetonitrile was used as mobile phase A, and 0.2% phosphoric acid solution was used as mobile phase B, and gradient elution was performed; the flow rate was 1.0 ml / min; the detection wavelength was 260 nm; and the column temperature was 25° C. The gradient elution process is as follows: 0-15min, mobile phase A: 10%→20%, mobile phase B: 90%→80%; 15-30 min, mobile phase A: 20% → 30%, mobile phase B: 80% → 70%; 30-50min, mobile phase A: 30%→50%, mobile phase B: 70%→50%.
10. Use of the Rhizoma Coptidis Chinese medicinal composition as claimed in claim 1 in preparing Rhizoma Coptidis toothpaste, characterized in that: The content of the Rhizoma Coptidis extract in the Rhizoma Coptidis toothpaste is controlled to be ≥1.5 mg / 100 g, and the Rhizoma Coptidis extract includes epiberberine, coptisine, palmatine and berberine.
